ADx Neurosciences

ADx NeuroSciences is a research-driven company specializing in the development of neurodegenerative biomarkers. It is currently collaborating with top pharmaceutical and diagnostic companies in the United States, Europe, Japan, and China. These collaborations have led to new diagnostic tests that support the development of promising drugs by monitoring drug efficacy or selecting suitable patients in the early stages of disease. These assays are used for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease and can be applied across various platforms for research up to IVD use. ADx NeuroSciences has developed proprietary state-of-the-art biomarker diagnostic assays. ADx Neurosciences provides cutting-edge biomarker testing for neurodegenerative diseases, creating tailored antibodies and detection methods to quantify unique biomarkers in various neurodegenerative diseases and conditions, such as Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company’s assays enable early detection before symptoms appear, offering valuable information from the drug development stage to clinical practice to improve patients' lives.